In trying to better predict a patient’s response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die. And in order to further examine this mechanism, researchers also created a new vehicle for pre-clinical testing of cancer treatments that acts as a bridge between experimental models and human subjects.